MT-4561

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameMT-4561
Drug Alias NameMT-4561
ClassificationOther
Mechanisms of ActionBromodomain-containing protein 4 degraders
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsProstatic NeoplasmsUterine Cervical NeoplasmsEndometrial Neoplasms +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma America IncMitsubishi Tanabe Pharma Corp
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsUterine Cervical NeoplasmsEndometrial Neoplasms +[16] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A